Nextel Medical Corp.

MAJIdata completeness 75%6 fiscal years on file

Data notes: no data for concept 'capex'; no data for concept 'totalDebt'; no data for concept 'pretaxIncome'

i. The business — what you’d actually own

Figure	FY 2011	FY 2012	FY 2018	FY 2019	FY 2020
Revenue	$0¹	$0¹	$0²	$0³	$0³
Net income	−$100,614⁴	−$6.07M⁴	−$575⁵	−$125,164⁶	−$435,950⁶
Operating cash flow	−$64,246⁷	−$215,427⁷	−$884⁸	−$9,297⁹	−$169,731⁹
Capital expenditure	—	—	—	—	—
Free cash flow (derived)	—	—	—	—	—
Total debt	—	—	—	—	—
Cash & equivalents	$71,160¹⁰	$5,865¹⁰	$1,589¹¹	$0¹¹	$0¹¹
Diluted shares	97.5M	48.8M	249.8M	249.8M	249.8M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal

If you owned

Net assets behind them

−$0.02

your share of equity

Profit it earned you last year

−$0.02

Free cash flow it threw off

—

Debt you’d be carrying

—

10 shares is a claim on −$0.02 of net worth that earned you −$0.02 last year.

iii. Is this a good business?

Moat signal · return on equity

— avg · 5y

Not enough data in the filings for a return-on-capital reading.

Management signal · capital allocation

+156% shares · 5y

Share count is up 156% over 5 years — owners have been diluted. Worth asking what they got for it.

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.1.0

DCF · Growth Exit 10Y

not applicable

only 0 years of FCF (need ≥3) — model not applicable

DCF · Growth Exit 5Y

not applicable

only 0 years of FCF (need ≥3) — model not applicable

Earnings Power Value

not applicable

normalized (5y-median) earnings non-positive — EPV undefined

Graham Number

not applicable

diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts